- Home
- KTF vs AMLX Comparison
KTF vs AMLX Comparison
Compare KTF & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTF
- AMLX
- Stock Information
- Founded
- KTF 1988
- AMLX 2014
- Country
- KTF United States
- AMLX United States
- Employees
- KTF N/A
- AMLX N/A
- Industry
- KTF Finance Companies
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- KTF Finance
- AMLX Health Care
- Exchange
- KTF Nasdaq
- AMLX Nasdaq
- Market Cap
- KTF 352.2M
- AMLX 330.5M
- IPO Year
- KTF N/A
- AMLX 2022
- Fundamental
- Price
- KTF $9.18
- AMLX $4.61
- Analyst Decision
- KTF
- AMLX Buy
- Analyst Count
- KTF 0
- AMLX 5
- Target Price
- KTF N/A
- AMLX $9.60
- AVG Volume (30 Days)
- KTF 103.3K
- AMLX 1.0M
- Earning Date
- KTF 01-01-0001
- AMLX 05-08-2025
- Dividend Yield
- KTF 3.54%
- AMLX N/A
- EPS Growth
- KTF N/A
- AMLX N/A
- EPS
- KTF 0.39
- AMLX N/A
- Revenue
- KTF N/A
- AMLX N/A
- Revenue This Year
- KTF N/A
- AMLX N/A
- Revenue Next Year
- KTF N/A
- AMLX N/A
- P/E Ratio
- KTF $23.10
- AMLX N/A
- Revenue Growth
- KTF N/A
- AMLX N/A
- 52 Week Low
- KTF $7.40
- AMLX $1.58
- 52 Week High
- KTF $9.12
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- KTF 54.57
- AMLX 52.12
- Support Level
- KTF $9.10
- AMLX $4.65
- Resistance Level
- KTF $9.21
- AMLX $5.34
- Average True Range (ATR)
- KTF 0.08
- AMLX 0.44
- MACD
- KTF 0.04
- AMLX -0.07
- Stochastic Oscillator
- KTF 92.44
- AMLX 25.98
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.